Volume 25, Issue 11, Pages (November 2017)

Slides:



Advertisements
Similar presentations
Volume 14, Issue 3, Pages (September 2006)
Advertisements

Hepatic AAV Gene Transfer and the Immune System: Friends or Foes?
Volume 22, Issue 4, Pages (April 2014)
Volume 16, Issue 8, Pages (August 2008)
Volume 22, Issue 8, Pages (August 2014)
Volume 12, Issue 5, Pages (November 2005)
Volume 24, Issue 2, Pages (February 2016)
Volume 19, Issue 2, Pages (February 2011)
Volume 22, Issue 12, Pages (December 2014)
Intraspinal AAV Injections Immediately Rostral to a Thoracic Spinal Cord Injury Site Efficiently Transduces Neurons in Spinal Cord and Brain  Michelle.
Thomas E. Arnold, MD, Dmitri Gnatenko, PhD, Wadie F. Bahou, MD 
Volume 20, Issue 1, Pages (January 2012)
Volume 2, Issue 5, Pages (November 2000)
Volume 18, Issue 12, Pages (December 2010)
Volume 26, Issue 2, Pages (February 2018)
Molecular Therapy - Oncolytics
Volume 16, Issue 4, Pages (April 2002)
The pathophysiology of abdominal aortic aneurysm growth: Corresponding and discordant inflammatory and proteolytic processes in abdominal aortic and popliteal.
Volume 19, Issue 11, Pages (November 2011)
Volume 18, Issue 6, Pages (June 2010)
Volume 16, Issue 8, Pages (August 2008)
Volume 19, Issue 2, Pages (February 2011)
Volume 18, Issue 4, Pages (April 2010)
Toxicology Study of Intra-Cisterna Magna Adeno-Associated Virus 9 Expressing Iduronate-2-Sulfatase in Rhesus Macaques  Juliette Hordeaux, Christian Hinderer,
Molecular Therapy - Methods & Clinical Development
Volume 18, Issue 11, Pages (November 2010)
AAV8 Can Induce Innate and Adaptive Immune Response in the Primate Eye
Molecular Therapy - Methods & Clinical Development
Volume 13, Issue 3, Pages (March 2006)
Volume 25, Issue 12, Pages (December 2017)
Molecular Therapy - Methods & Clinical Development
Prevention of Irradiation-induced Salivary Hypofunction by Microvessel Protection in Mouse Salivary Glands  Ana P Cotrim, Anastasia Sowers, James B Mitchell,
Premal Lulla, Carlos A. Ramos  Molecular Therapy 
Response of Psoriasis to Interleukin-10 is Associated with Suppression of Cutaneous Type 1 Inflammation, Downregulation of the Epidermal Interleukin-8/CXCR2.
Volume 23, Issue 3, Pages (March 2015)
Volume 18, Issue 1, Pages (January 2010)
Long-term Improvements in Lifespan and Pathology in CNS and PNS After BMT Plus One Intravenous Injection of AAVrh10-GALC in Twitcher Mice  Mohammad A.
133. Survival with Normal Neurological Development of the Juvenile Lethal Urea Cycle Defect Arginase Deficient Mouse with AAV Gene Therapy    Molecular.
Volume 18, Issue 1, Pages (January 2010)
Volume 18, Issue 4, Pages (April 2010)
660. Bowel/Bladder Sensation and Control in Patients with Spinal Cord Injury Treated with Human Embryonic Stem Cell Therapy  Geeta Shroff  Molecular Therapy 
Volume 12, Issue 5, Pages (November 2005)
The Neurotropic Properties of AAV-PHP.B Are Limited to C57BL/6J Mice
Volume 12, Issue 3, Pages (September 2005)
Volume 14, Issue 1, Pages (July 2006)
Volume 22, Issue 2, Pages (February 2014)
674. Molecular, Biochemical and Biomechanical Analysis of Articular Cartilage Repaired with Genetically Modified Chondrocytes Expressing Insulin-Like.
Volume 10, Issue 4, Pages (October 2004)
Evidence for an Age-Dependent Decline in Axon Regeneration in the Adult Mammalian Central Nervous System  Cédric G. Geoffroy, Brett J. Hilton, Wolfram.
Volume 19, Issue 6, Pages (June 2011)
372. Targeted Mutagenesis of Ubiquitin-Binding Lysine Residues on the Adeno- Associated Virus (AAV)2 Capsid Improves Its Transduction Efficiency    Molecular.
Volume 26, Issue 2, Pages (February 2018)
Kasey L Jackson, Robert D Dayton, Ronald L Klein 
The Lymphocytic Choriomeningitis Virus Envelope Glycoprotein Targets Lentiviral Gene Transfer Vector to Neural Progenitors in the Murine Brain  Colleen.
J.M.I. Malik, Z. Shevtsova, M. Bähr, S. Kügler  Molecular Therapy 
Volume 13, Issue 3, Pages (March 2006)
740. Prevention of Radiation-Induced Lung Injury by Administration of Gene-Modified Mesenchymal Stem Cells    Molecular Therapy  Volume 20, Pages S285-S286.
Molecular Therapy  Volume 21, Pages S247-S248 (May 2013)
Volume 26, Issue 1, Pages (January 2018)
Volume 18, Issue 6, Pages (June 2010)
Volume 20, Issue 9, Pages (September 2012)
Moutih Rafei, Elena Birman, Kathy Forner, Jacques Galipeau 
Volume 8, Issue 2, Pages (August 2003)
Volume 21, Issue 1, Pages (January 2013)
Volume 13, Issue 4, Pages (April 2006)
Molecular Therapy - Oncolytics
Zhijian Wu, Aravind Asokan, R. Jude Samulski  Molecular Therapy 
Volume 16, Issue 10, Pages (October 2008)
Volume 13, Issue 1, Pages (January 2006)
Volume 16, Issue 4, Pages (April 2008)
Presentation transcript:

Volume 25, Issue 11, Pages 2526-2532 (November 2017) Fatal Meningitis in Swine after Intrathecal Administration of Adeno-associated Virus Expressing Syngeneic Interleukin-10  Mark D. Unger, Josef Pleticha, James E. Collins, Anibal G. Armien, Jennifer L. Brazzell, Laura K. Newman, Lukas F. Heilmann, Jodi A. Scholz, Timothy P. Maus, Andreas S. Beutler  Molecular Therapy  Volume 25, Issue 11, Pages 2526-2532 (November 2017) DOI: 10.1016/j.ymthe.2017.07.016 Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions

Figure 1 Neuropathology of Moribund Animals (A–F) Representative H&E-stained images of the cerebellum (A and B), forebrain (C), brainstem (D), and spinal cord (E and F). The meninges were diffusely expanded by lymphocytic infiltrates (A–C and F), vascular congestion (arrowhead; A), and lymphatic distension (plus sign; C). Meningeal infiltration extended along the Virchow-Robin space forming perivascular cuffs (asterisk; D and E) and into adjacent gray matter with mild gliosis (arrows; C). Meningeal infiltrates were predominately lymphocytic with mild numbers of eosinophils in cerebellar meninges (B) and few plasma cells and macrophages. Evidence of an infectious agent was not identified in any image. Scale bars represent 75 μm. Representative images in (A)–(D) are from three moribund animals of the first cohort (n = 25 images). Representative images in (E) and (F) are from two moribund animals of the replication experiment (n = 55 images). For additional images, see also Figure S3. Molecular Therapy 2017 25, 2526-2532DOI: (10.1016/j.ymthe.2017.07.016) Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions

Figure 2 IL-10 Concentration in CSF and Survival Period in Swine CSF obtained by serial lumbar puncture was measured for IL-10 concentration. Each symbol represents the IL-10 concentration measured from one CSF sample per time point. Abbreviated time series (red) were obtained from animals exhibiting fulminant neurotoxicity, requiring premature euthanasia (time of death, black cross). Gray time series represent animals that survived to final study day 56 (survived, black pig). The first cohort (open symbols) comprised 28 CSF samples from five animals. The second cohort (closed symbols) comprised six CSF samples from two animals. Time is defined as weeks after pIL-10/AAV8 administration. CSF IL-10 concentrations obtained prior to vector administration (baseline) were below the assay detection level (5 × 10−3 pg/mL, horizontal dotted line) for all animals. Molecular Therapy 2017 25, 2526-2532DOI: (10.1016/j.ymthe.2017.07.016) Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions

Figure 3 Cellular Characteristics of CNS Inflammatory Infiltrates (A–F) Representative images of immunoperoxidase-stained spinal cords depicting CD3+ T lymphocytes (A–C) and CD20+ B lymphocytes (D–F). The majority of infiltrating cells found within the spinal leptomeninges (A and D), perivascular cuffs of spinal gray matter (B and E), and along the central canal (C and F) were T lymphocytes and a minority were B lymphocytes. (A) T lymphocytes infiltrated the leptomeninges diffusely and extended along the Virchow-Robin space. (D) Infiltrating B lymphocytes localized to the CSF-facing side of the leptomeninges facing the i.t. space but did not extend along the Virchow-Robin space. Scale bars represent 150 μm. Molecular Therapy 2017 25, 2526-2532DOI: (10.1016/j.ymthe.2017.07.016) Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions